Article
Dual Ribosome Profiling reveals metabolic limitations of cancer and stromal cells in…
medRxiv · 2025 · Aviles Huerta, D.; Del Pizzo, R.; Kowar, A.; Baig, A. H.; Palazzo, G.; Stepanova, E.; Amaya Ramirez, C. C.; D'Agostino, S.; Ratto, E.; Pechincha, C.; Siefert, N.; Engel, H.; Du, S.; Cardenas-De Miguel, S.; Miao, B.; Cruz Vilchez, V.; Muller-Decker, K.; Elia, I.; Sun, C.; Palm, W.; Loayza-Puch, F.
Key facts
| Title | Dual Ribosome Profiling reveals metabolic limitations of cancer and stromal cells in thetumor microenvironment |
|---|---|
| First author | Aviles Huerta, D.; Del Pizzo, R.; Kowar, A.; Baig, A. H.; Palazzo, G.; Stepanova, E.; Amaya Ramirez, C. C.; D'Agostino, S.; Ratto, E.; Pechincha, C.; Siefert, N.; Engel, H.; Du, S.; Cardenas-De Miguel, S.; Miao, B.; Cruz Vilchez, V.; Muller-Decker, K.; Elia, I.; Sun, C.; Palm, W.; Loayza-Puch, F. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.01.08.631877 |
| Devices mentioned | K040782, K073490 |
| Product codes mentioned | CFN, JAK, MVU, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1